Second-line treatment options in advanced non-small cell lung cancer

被引：5
|
作者：
de Marinis, Filippo [1 ]
Ricciardi, Serena [1 ]
机构：
[1] San Camillo Forlanini High Specializat Hosp, Lung Dis Dept, Pulm Oncol Unit 1, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
RANDOMIZED PHASE-III; PREVIOUSLY TREATED PATIENTS; GROWTH-FACTOR RECEPTOR; QUALITY-OF-LIFE; EVERY; WEEKS; SINGLE-AGENT; MOLECULAR PREDICTORS; PLUS GEMCITABINE; WEEKLY DOCETAXEL; SUPPORTIVE CARE;
D O I：
10.1016/S0959-8049(11)70172-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S258 / S271
页数：14
相关论文
共 50 条
  • [1] Second-line treatment options in advanced non-small cell lung cancer: Current status
    Cullen, M
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S3 - S8
  • [2] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [3] The safety of second-line treatment options for non-small cell lung cancer
    Rossi, Antonio
    Maione, Paolo
    Santabarbara, Giuseppe
    Sacco, Paola Claudia
    Casaluce, Francesca
    Sgambato, Assunta
    Barzelloni, Maria Luisa
    Palazzolo, Giovanni
    Gridelli, Cesare
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 471 - 479
  • [4] Evaluation of second-line treatment options in non-small cell lung cancer - Introduction
    Scagliotti, GV
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S1 - S2
  • [5] SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Cullen, M.
    [J]. LUNG CANCER, 2009, 64 : S13 - S13
  • [6] Advanced non-small cell lung cancer. Maintenance and second-line treatment
    Schuette, W.
    Nagel, S.
    Haak, G.
    Steinert, M.
    [J]. PNEUMOLOGE, 2012, 9 (01): : 43 - 48
  • [7] Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
    J. Feliu
    G. Martín
    J. Castro
    A. Sundlov
    A. Rodriguez-Jaráiz
    E. Casado
    M. Lomas
    C. Madroñal
    A. Galán
    C. Belda
    M. Gonzalez-Barón
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58 : 527 - 531
  • [8] Second-line treatment for advanced non-small cell lung cancer:: A systematic review
    Barlési, F
    Jacot, W
    Astoul, P
    Pujol, JL
    [J]. LUNG CANCER, 2006, 51 (02) : 159 - 172
  • [9] Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
    Feliu, J.
    Martin, G.
    Castro, J.
    Sundlov, A.
    Rodriguez-Jaraiz, A.
    Casado, E.
    Lomas, M.
    Madronal, C.
    Galan, A.
    Belda, C.
    Gonzalez-Baron, M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 527 - 531
  • [10] Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Ardizzoni, A
    Tiseo, M
    [J]. JOURNAL OF CHEMOTHERAPY, 2004, 16 : 104 - 107
12345